Hemp Product Market Future Backed By McConnell, Fate Depends On Farm Bill
This article was originally published in The Rose Sheet
The surprising support of Senate majority leader Mitch McConnell is integral to the success of a provision in legislation to reauthorize USDA programs that would clarify hemp's removal from the federal list of controlled substances and ease limits on its production in the US. Meanwhile, Charlotte's Web Holdings' recent $100m IPO is a strong sign of investors' confidence in the future market for hemp products.
You may also be interested in...
DEA’s explanation delta-8 THC acetate isn’t hemp, along with FDA’s hemp and cannabis policies chief saying it and other cannabis derivatives aren’t hemp, should simplify decision on lawful use of hemp in non-drug products subject to FDA’s regulatory oversight.
Nearly three years later, lawmakers who backed de-scheduling hemp might question whether language in the farm bill opened a door too far, or omitted sufficient detail to prevent confusion over what meets the law's definition of hemp.
Kentucky's junior senator re-introduced legislation to raise from 0.3% to 1% the level of THC by dry weight that Congress defined as legal hemp in the 2018 farm bill.